Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

to related objects

Location: Deutsche Nationalbibliothek Frankfurt am Main

Extent: 1 Online-Ressource.

Language: Englisch

Bibliographic citation: Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform ; volume:15 ; number:1 ; day:2 ; month:10 ; year:2023 ; pages:1-11 ; date:12.2023
Alzheimer's research & therapy ; 15, Heft 1 (2.10.2023), 1-11, 12.2023

Creator: Martínez-Dubarbie, Francisco
Guerra-Ruiz, Armando
López-García, Sara
Lage, Carmen
Fernández-Matarrubia, Marta
Infante, Jon
Pozueta-Cantudo, Ana
García-Martínez, María
Corrales-Pardo, Andrea
Bravo, María
López-Hoyos, Marcos
Irure-Ventura, Juan
Sánchez-Juan, Pascual
García-Unzueta, María Teresa
Rodríguez-Rodríguez, Eloy

Contributor: SpringerLink (Online service)

DOI: 10.1186/s13195-023-01319-1

URN: urn:nbn:de:101:1-2024020612532443958725

Rights: Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.

Last update: 15.08.2025, 7:29 AM CEST

Data provider

This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.

Show original at data provider

Associated

Martínez-Dubarbie, Francisco
Guerra-Ruiz, Armando
López-García, Sara
Lage, Carmen
Fernández-Matarrubia, Marta
Infante, Jon
Pozueta-Cantudo, Ana
García-Martínez, María
Corrales-Pardo, Andrea
Bravo, María
López-Hoyos, Marcos
Irure-Ventura, Juan
Sánchez-Juan, Pascual
García-Unzueta, María Teresa
Rodríguez-Rodríguez, Eloy
SpringerLink (Online service)

Other Objects (12)

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Pathological phenotypes of astrocytes in Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Pathological phenotypes of astrocytes in Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Pathological phenotypes of astrocytes in Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Cultural heritage institutions wishing to register will find more information here.

Fields marked * need to be filled in.

Username*

Please enter your username

Email*

Please enter your email address

Please do not fill this field

First name

Last name

Password*

Please enter your password

Confirm password*

Please enter the same password

I have read the terms of use and the privacy policy for the collection of personal data and accept them. *

This field is required.

I would like to subscribe to the newsletter of the Deutsche Digitale Bibliothek. See newsletter subscription info.

Account created

Your "My DDB" account has been successfully created. Before you can log in to your account, you must click the confirmation link in the message we just sent to the email address you provided.

Accuracy of plasma Aβ40, Aβ42, and p-tau181 to detect CSF Alzheimer’s pathological changes in cognitively unimpaired subjects using the Lumipulse automated platform

Object Details

References and Relationships

Contributors, Places and Time

Further information

Data provider

Associated

Other Objects (12)

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Pathological phenotypes of astrocytes in Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Pathological phenotypes of astrocytes in Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Distinct CSF biomarker-associated DNA methylation in Alzheimer’s disease and cognitively normal subjects

Ultrasensitive tau biosensor cells detect no seeding in Alzheimer’s disease CSF

Increased CSF-decorin predicts brain pathological changes driven by Alzheimer’s Aβ amyloidosis

Genetic data and cognitively defined late-onset Alzheimer’s disease subgroups

Pathological phenotypes of astrocytes in Alzheimer’s disease

Decline in cognitively complex everyday activities accelerates along the Alzheimer’s disease continuum

CSF Presenilin-1 complexes are increased in Alzheimer’s disease

Levels of ADAM10 are reduced in Alzheimer’s disease CSF

Alzheimer’s disease CSF biomarkers: clinical indications and rational use

An olfactory ‘stress test’ may detect preclinical Alzheimer’s disease

Cognitively impaired aged Octodon degus recapitulate major neuropathological features of sporadic Alzheimer’s disease

Decreased CSF clearance and increased brain amyloid in Alzheimer’s disease

Related objects

Reset password